Contraception

Papers
(The TQCC of Contraception is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
POSTER ABSTRACTS86
Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortion73
CLINICAL ORAL ABSTRACTS57
A survey of contraceptive method use among patients with delayed permanent contraception due to the COVID-19 pandemic57
POSTER ABSTRACTS55
Clinic factors associated with utilization of a pregnancy-intention screening tool in community health centers48
Building the capacity of young professionals in family planning to publish: Insights from the ICFP2022 WHO scientific writing, mentoring and coaching course47
The association between depression and contraceptive behaviors in a diverse sample of new prescription contraception users46
POSTER ABSTRACTS36
Editorial Board36
POSTER ABSTRACTS34
POSTER ABSTRACTS34
Advancing diversity, equity, inclusion, and anti-racism in Contraception: A statement of commitment from the Editorial Board33
Money and place: Quantifying the types of obstacles associated with seeking an abortion after 10 weeks’ gestation, 2019–202030
Importance of abortion training to United States Obstetrics and Gynecology residency applicants in 202329
A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals29
Modeling the impact of decreasing waiting period length for Medicaid sterilization: A multi-site cohort study28
Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification23
ORAL ABSTRACTS23
Copyright info/Contents22
Factors influencing women's decisions about pregnancy spacing: Findings from a focus group discussion study21
POSTER ABSTRACTS21
POSTER ABSTRACTS20
Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States20
POSTER ABSTRACTS20
POSTER ABSTRACTS20
Weighing risk and centering patients within clinical guidelines19
POSTER ABSTRACTS19
POSTER ABSTRACTS19
POSTER ABSTRACTS18
Use of nonpreferred contraceptive methods among women in Ohio18
POSTER ABSTRACTS17
Editorial Board17
POSTER ABSTRACTS17
A randomized controlled trial of methylergonovine prophylaxis after dilation and evacuation abortion16
POSTER ABSTRACTS16
Serum human chorionic gonadotropin decline following aspiration abortion in early pregnancy less than 42 days gestation16
Online community queries on hormonal male contraception: An analysis of the Reddit “Ask Me Anything” experience16
SOCIAL SCIENCE ORAL ABSTRACTS16
Reasons for Participation in Abortion Research in Restrictive Settings15
Transparency around abortion training on obstetrics and gynecology residency program websites15
Copyright info/Contents15
Effect of a single dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s) users: A randomized double-blind placebo-controlled trial15
One-day versus two-day mifepristone–misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study15
Impact of the hands-on clinical training program for subdermic implant on contraceptive counseling and users' choice in Spain: A 6-month follow-up study15
NAVIGATING CRISIS PREGNANCY CENTERS: A SCOPING REVIEW15
USING PARTICIPATORY DESIGN TO CREATE ADOLESCENT-CENTERED CONTRACEPTIVE COUNSELING TEAR SHEETS TO SUPPORT EXPLORATION, DECISION MAKING, AND USE14
RESTRICTIVE ABORTION LEGISLATION CREATES UNCERTAINTY AMONG PRIMARY CARE AND EMERGENCY CLINICIANS14
THE PHARMACOKINETICS OF 5 MG NORETHINDRONE ACETATE VS. 0.35 MG NORETHINDRONE14
UNSATISFIED CONTRACEPTIVE PREFERENCES AND REASONS FOR NON-PREFERRED USE AMONG PREGNANCY-CAPABLE PEOPLE IN THE US, 202114
ASSOCIATION OF EXPANDED MEDICAID COVERAGE TO 12 MONTHS POSTPARTUM WITH CONTRACEPTIVE USE IN SOUTH CAROLINA14
CHARACTERIZING THE SEXUAL AND REPRODUCTIVE HEALTH NEEDS OF WOMEN EXPERIENCING HOUSING INSTABILITY FROM THE NATIONAL SURVEY OF FAMILY GROWTH, 2017–201914
Copyright info/Contents13
BLEEDING AND PAIN OVER TIME WITH A NOVEL LOW-DOSE COPPER INTRAUTERINE DEVICE WITH A FLEXIBLE NITINOL FRAME13
EVALUATION OF HEALTH-RELATED QUALITY OF LIFE IN THE ABORTION CARE SETTING: A UTILITY-SCORE VALIDATION STUDY13
The US Supreme Court Dobbs decision’s impact on the future plans of 2023 residency graduates at the University of Utah13
DOES CONTRACEPTIVE METHOD DISSATISFACTION DIFFER BY TYPE OF DISABILITY?13
THE INTERSECTION OF ENGLISH PROFICIENCY AND NATIVITY IN RECEIPT OF PERSON-CENTERED CONTRACEPTIVE COUNSELING13
A RANDOMIZED STUDY OF DOUBLE- VS. SINGLE-DOSE ETONOGESTREL IMPLANT FOR WOMEN WITH HIV ON EFAVIRENZ-BASED ANTIRETROVIRAL THERAPY: THE DOUBLET STUDY13
A NATIONAL SNAPSHOT OF ABORTION TRAINING IN FAMILY MEDICINE RESIDENCY PROGRAMS12
“I HAVE INSURANCE BUT I’M UNSURE IF I’M COVERED”: EVALUATING 13 MONTHS OF MESSAGES TO A YOUTH-FOCUSED, REPRODUCTIVE JUSTICE TEXT LINE IN MISSOURI12
PROCEDURAL OUTCOMES COMPARING TRANSCERVICAL BALLOON WITH OSMOTIC DILATORS PRIOR TO PROCEDURAL ABORTION: A NON-INFERIORITY RANDOMIZED TRIAL12
PREDICTORS OF ABORTION PROVISION AMONG OBSTETRICIAN-GYNECOLOGISTS IN MASSACHUSETTS12
Copyright info/Contents12
ABORTION CARE PREFERENCES AND TRADE-OFFS WHEN TRAVELING OUT OF STATE FOR FACILITY-BASED SERVICES12
The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study12
ESTIMATED INCREASE IN SEVERE MATERNAL MORBIDITY DUE TO A TOTAL ABORTION BAN IN THE US12
Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis11
Editorial Board11
Access to sexual and reproductive health services among South African young people living with and without HIV during the COVID-19 pandemic11
Improvement in contraceptive knowledge after using an online educational resource11
Feasibility of methadone for pain relief in first trimester abortion11
Exploring the prevalence of abortion and its characteristics in Perú11
Religious affiliation and women’s receipt of person-centered contraceptive care: Findings from the National Survey of Family Growth, 2017–201911
Editorial Board10
O12Barriers to abortion access for young southerners: a qualitative analysis of case notes from arc-southeast10
P025Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment10
Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access10
P027Abortion complexity and abortion identity: Findings from the ohio survey of women10
O20Trauma responsive abortion care (on trac study): The abortion experiences of patients with a history of trauma10
Dextromethorphan as a novel nonopioid adjunctive agent for pain control with medication abortion: A randomized controlled trial10
Infectious outcomes following immediate postplacental intrauterine device placement in the setting of chorioamnionitis: An exploratory, retrospective study10
P010Healthcare at the margins: The role of healthcare providers in self-managed abortion near the us-mexico border10
P096Nexplanon training: Knowledge, experience, and perspectives among family medicine residents and preceptors in new jersey9
P047Physician beliefs about abortion safety and their participation in abortion care9
P095Let's chat: Initial feasibility, usability, and acceptability of a novel adolescent-centered sexual and reproductive care web-based app9
P100Stigma and social norms as drivers of partner support during pregnancy decision making: Results of a focus group study among cisgender men9
P046Impact of birthing volumes on abortion provision and surgical miscarriage management9
Use of a contraceptive decision support tool in the abortion care setting9
P033Patient acceptability of asynchronous vs synchronous telehealth medication abortion care in the US9
P081And then what happened? Assessing contraceptive use outcomes over three years among participants in the her salt lake contraceptive initiative9
Long-acting reversible contraception and condom use: A cohort study of female adolescents and young adults in New York City9
P097Resident initiated obstetrics and gynecology didactics as a method of keeping up with the evolving abortion legislative landscape9
P040“You're on your own”: A qualitative analysis of texas senate bill 8 on abortion care in patients with lethal or life-limiting fetal diagnoses9
P045Sexual orientation among a national sample of people obtaining abortions in 2021–20229
P086Documentation status and contraceptive use among women in california9
P057Levonorgestrel 52 mg intrauterine system efficacy and safety after eight years of use9
Editorial Board9
When doctors are “doxxed:” An analysis of information posted on an antiabortion website8
The role of advanced training in family planning and reproductive health in a low-income country; the experience of Ethiopia8
The next two decades of mifepristone at FDA: History as destiny,8
Time from first clinical contact to abortion in Texas and California8
Perceptions of Legality and Availability of Abortion Care in Mississippi8
Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception8
Contraceptive plans before preoperative assessment and at procedure in surgical abortion patients8
Acceptability of the contraceptive Sayana® Press when injected every four months: Results from a twelve-month trial in Brazil, Chile and the Dominican Republic8
A real-world comparison of in-person vs. virtual contraceptive care trainings for clinicians and support staff8
Fetomaternal hemorrhage assessment in Rh-negative patients undergoing dilation and evacuation between 20 and 24 weeks’ gestational age: A retrospective cohort study8
Surgical uterine evacuation in patients with two cervices: a case series8
Fetal tissue donation for research at the time of abortion: A qualitative study of individuals who experienced an abortion in Hawaii in 2018-198
Copyright info/Contents8
Non-barrier contraceptive use patterns among Latina adolescents attending California reproductive health centers: A longitudinal study8
Abortion research that matters: Using core outcomes to enable systematic review8
Editorial Board8
Effect of neighborhood-level income on access to emergency contraception8
Integrating anti-violence efforts into sexual and reproductive health: Reproductive coercion as a case example8
Accessibility to postpartum tubal ligation after a vaginal delivery: When the Medicaid policy is not a limiting factor8
Opportunities for improving provision of emergency contraception in California8
Telemedicine Abortion During the COVID Pandemic in Mexico City8
Copyright info/Contents8
Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product7
Association of perinatal depression and postpartum contraception intent, choice, and actual use7
Exploring Canadians’ Experiences with Belief-based Denial of Contraception and Abortion Care7
Announcement7
Youth opinions about Title X funding and policy in the United States: A mixed methods text message survey7
Contraception information on the websites of student health centers in the United States7
Society of Family Planning Annual Meeting 20227
“It’s different than a doctor saying ‘You’re making the right choice’”: A qualitative study of chaplains’ experience caring for patients undergoing abortion in Washington DC, Maryland, and Virginia7
Changes in contraceptive method mix following the Colorado Family Planning Initiative7
Association of rural location and long acting reversible contraceptive use among Oregon Medicaid recipients7
Post-ablation tubal sterilization syndrome: Does route of sterilization matter?7
002Abortion patients’ priorities and tradeoffs deciding where to obtain out-of-state care following texas 2021 abortion ban7
Effectiveness of fertility awareness-based methods for pregnancy prevention during the postpartum period7
Prescription opioid fills following surgical abortion7
Population differences in responses to male hormonal contraception (lessons learned from the WHO-CONRAD phase III study)7
“We're called upon to be nonjudgmental”: A qualitative exploration of United States medical students’ discussions of abortion as a reflection of their professionalism6
Postpartum contraception method type and risk of a short interpregnancy interval in a state Medicaid population6
The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States6
Implementation of telemedicine preoperative visits for abortion procedures through 18 weeks gestation at a Northern California hospital-based center6
Abortion restrictions in the state of Georgia: Anticipated impact on people seeking abortion6
Prevalence of contraindications to progestin-only contraceptive pills in a multi-institution patient database6
Pain management for medical abortion before 14 weeks’ gestation: A systematic review6
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens6
Using the person-centered contraceptive counseling (PCCC) measure for quality improvement6
Immigration Policy Climate and contraceptive use among Mexican-origin women in the United States: Support for the “spill-over” hypothesis6
Complex family planning and pediatric hematology oncology integrated clinic for young people with blood disorders and heavy or abnormal menstrual bleeding6
Removal of nonpalpable etonogestrel implants after fixation with a curved needle—A case series,6
Availability of mifepristone and misoprostol in Oregon pharmacies: A comparison by rural and urban status6
Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist6
ORAL ABSTRACTS6
Mechanical dilation to remove incarcerated laminaria during a second trimester abortion6
A pilot quasi-experimental controlled trial of a community-based, multilevel family planning intervention for couples in rural Uganda: evidence of feasibility, acceptability, and effect on contracepti6
Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens6
Copyright info/Contents6
A Canadian survey of patients’ attitudes toward donation of products of conception for research at the time of their aspiration abortion6
From training to implementation: Improving contraceptive practices in South Carolina6
Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States6
Female permanent contraception policies and occurrence at a sample of U.S. prisons and jails6
Editorial Board6
Society of Family Planning clinical recommendation: Extended use of long-acting reversible contraception6
Society of Family Planning clinical recommendations: Pain control in surgical abortion part 2 – Moderate sedation, deep sedation, and general anesthesia6
Exploring the emotional costs of abortion travel in the United States due to legal restriction6
Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years6
How do women interpret abortion information they find online?6
Feasibility of methadone for pain relief in first trimester abortion (Boston, Massachusetts 2022)6
Deception by obfuscation: Studnicki et al.’s retracted longitudinal cohort study of emergency room utilization following abortion6
Is it an abortion: Classification of pregnancy-ending interventions after 24 weeks in the presence of lethal fetal anomalies6
Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial5
A prospective cohort study to assess the acceptability of Sayana Press among 18–49-year-old women in Nepal5
PHARMACIST ATTITUDES TOWARDS ADMINISTRATION OF DEPOT-MEDROXYPROGESTERONE ACETATE FOR CONTRACEPTION IN THE OUTPATIENT SETTING5
Patient Acceptability of Asynchronous vs Synchronous Telehealth Abortion Care: A Cohort Study of Telehealth Abortion Care Provided by Virtual Clinics in the United States5
Telemedicine for contraceptive counseling: Patient experiences during the early phase of the COVID-19 pandemic in New York City5
Single-visit insertion of long-acting reversible contraception in a single health system5
STUDENT EXPERIENCES WITH EMERGENCY CONTRACEPTION AND PREFERENCES FOR ON-CAMPUS VENDING MACHINES5
CHANGES IN BELIEFS ABOUT ABORTION SAFETY IN A NATIONALLY REPRESENTATIVE SAMPLE BETWEEN 2022 AND 20235
The association of patient age, race, and demographic features on reported pain and sedation dosing during procedural abortion: A retrospective cohort study5
Greasing the wheels: The impact of COVID-19 on US physician attitudes and practices regarding medication abortion5
ABORTION-RELATED COSTS AS CATASTROPHIC HEALTH EXPENDITURES AND THEIR ASSOCIATIONS WITH IN-STATE OR OUT-OF-STATE TRAVEL TO ABORTION CARE5
Timing of pregnancy discovery among women seeking abortion,5
Vomiting and risk of endotracheal intubation related to preoperative doxycycline use for dilation and evacuation5
“IT DEPENDS ON THE PERSON AND…ON THE SITUATION TOO”: FACTORS INFLUENCING ABORTION METHOD PREFERENCES AMONG BLACK AND LATINX COMMUNITIES IN THE US SOUTHEAST5
MEN’S ABORTION ATTITUDES: RESULTS FROM AN ONLINE SURVEY OF MEN IN THE US AND CANADA5
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S5
Editorial Board5
“I never went to see that doctor again”: A qualitative study examining Australian women's experiences requesting removal of LARC within 12 months of insertion5
LEVONORGESTREL 52 MG INTRAUTERINE DEVICE PLACEMENT WITHOUT SOUNDING: A FEASIBILITY STUDY5
OB-GYN RESIDENT EXPERIENCE IN AN ABORTION-BAN STATE POST-DOBBS5
Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation5
An estimate of lifetime incidence of abortion in the United States using the 2021–2022 Abortion Patient Survey5
ADAPTATION AND VALIDATION OF THE CONTRACEPTIVE AGENCY SCALE FOR THE US5
Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients5
DISTANCES TRAVELLED FOR ABORTIONS AND INEQUITIES FOR RURAL RESIDENTS IN OREGON5
WHERE’S THE SPACE FOR JOY? A CALL FOR EXPANDED MEASUREMENT OF POSITIVE EMOTIONS AND ATTITUDES ASSOCIATED WITH ABORTION5
Society of Family Planning Clinical Recommendation: Emergency contraception5
Patient and obstetrician-gynecologist perspectives on considering long-acting reversible contraception for postpartum patients who desire permanent contraception5
THE ASSOCIATION OF INSERTION METHODS ON IMMEDIATE POSTPARTUM INTRAUTERINE DEVICE EXPULSION RATES: A RETROSPECTIVE COHORT STUDY5
DIFFERENCES IN TYPES OF CHALLENGES EXPERIENCED BY SEXUAL MINORITY AND HETEROSEXUAL PATIENTS SEEKING ABORTION CARE5
TRENDS IN OUT-OF-STATE ABORTIONS IN OREGON FOLLOWING THE DOBBS COURT DECISION5
Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States5
OHIO ABORTION SEEKERS CHALLENGED BY TWO-VISIT REQUIREMENT ARE LIKELY TO REPORT MORE CHALLENGES OVERALL5
Community-based distribution of misoprostol for early abortion: Outcomes from a program in Sindh, Pakistan5
ASSOCIATION BETWEEN EXPERIENCES OF DISCRIMINATION AND CONCERNS ABOUT ACCESSING CONTRACEPTIVE CARE AMONG COMMUNITY COLLEGE STUDENTS IN TEXAS AND CALIFORNIA5
POSTER ABSTRACTS4
Editorial Board4
POSTER ABSTRACTS4
Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations4
Letter to the Editor4
Society of Family Planning Research Practice Support: Strategies and considerations for addressing race and racism in quantitative family planning studies4
The impact of the SB 8 Texas abortion ban on pregnancy duration at time of abortion in a large volume Colorado clinic4
Self-reported follow-up care needs can be met in both facility and self-managed abortion: Evidence from low- and middle-income countries4
Development of a transdermal gel for reversible male contraception4
Association of body mass index on time to fetal expulsion for individuals undergoing medication abortion over 13 weeks gestational duration4
Society of Family Planning committee consensus on Rh testing in early pregnancy4
Patient and counselor satisfaction with structured contraceptive counseling by health center staff in federally qualified health centers4
US clinicians’ perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care4
Defying the odds: Facilitating integration of abortion care into clinical practice in the United States4
Adaptations to COVID-19 by US abortion clinics: Analysis of Society of Family Planning survey data4
Copyright info/Contents4
Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review4
Refugee women's experiences with contraceptive care after resettlement in high-income countries: A critical interpretive synthesis4
Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS124
Potential effect of immediate postpartum use of injectable contraception on lactogenesis4
Permanent contraception in the childfree population: An exploratory study4
Addendum to “Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study” [Contraception 131 (2024) 110344]4
Corrigendum to “An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States” Contraception, Volume 122, 14
Meeting people’s pregnancy prevention needs: Let’s not force people to state an “Intention”4
Society of Family Planning Clinical Recommendations: Contraceptive Care in the Context of Pandemic Response4
An introduction to risk evaluation and mitigation strategies4
Comparing transcervical balloon with osmotic dilators for cervical preparation prior to procedural abortion: A noninferiority randomized trial4
POSTER ABSTRACTS4
POSTER ABSTRACTS4
Health care access and contraceptive use among adult women in the United States in 20174
Validation of the contraception-focused Preference-aligned Fertility Management Index in Uganda and Nigeria4
GeneFlex—A Chinese generic intrauterine device not to be confused with GyneFix4
Corrigendum to Society of Family Planning Research Practice Support: Strategies and considerations for addressing race and racism in quantitative family planning studies [Contraception vol 139 (2024) 4
Editorial Board4
A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in person4
Return to fertility, toxicology, and transgenerational impact of treatment with WIN 18,446, a potential male contraceptive, in mice4
Elevating the patient voice in contraceptive care quality improvement: A qualitative study of patient preferences for peripartum contraceptive care4
Prioritizing patient experience: Validation of the person-centered contraceptive counseling measure as a performance measure4
Urgent concerns regarding EURAS-LCS12 article4
POSTER ABSTRACTS3
Using prevention cascades to investigate coverage of contraception services among young women enrolled in a large-scale combination HIV prevention program in South Africa3
“That’s a tricky one”: Access to misoprostol for early pregnancy loss in retail pharmacies across Arizona3
POSTER ABSTRACTS3
POSTER ABSTRACTS3
Contraceptive priorities among women seeking family planning services in Finland in 2017–20193
Fertility intentions and recent births among US abortion patients3
Language-based acculturation is linked with reproductive autonomy among Oregon Mexican-origin Latinas3
Telehealth contraceptive care in 2018: A quality improvement study of barriers to access and patient satisfaction3
0.1159348487854